Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,840 | 28,108 | 30,083 | 35,511 | 54,116 |
| Marketable Securities | 64,714 | 63,662 | 64,124 | 65,544 | 60,025 |
| Receivables | 1,032 | 679 | 783 | 2,036 | 2,136 |
| Other current assets | 1,010 | 2,000 | 1,437 | 1,300 | 851 |
| TOTAL | $93,371 | $96,620 | $97,907 | $105,580 | $118,148 |
| Non-Current Assets | |||||
| PPE Net | 9,324 | 5,804 | 2,864 | 1,328 | 538 |
| Investments And Advances | 69,412 | 93,087 | 104,810 | 107,853 | 102,526 |
| Other Non-Current Assets | 625 | 464 | 491 | 223 | 168 |
| TOTAL | $79,361 | $99,355 | $108,165 | $109,404 | $103,232 |
| Total Assets | $172,732 | $195,975 | $206,072 | $214,984 | $221,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,543 | 5,376 | 2,076 | 1,113 | 1,014 |
| Accrued Expenses | 8,126 | 9,006 | 7,073 | 4,633 | 3,198 |
| Other current liabilities | N/A | N/A | 0 | 35 | 127 |
| TOTAL | $9,669 | $14,382 | $9,149 | $5,781 | $4,339 |
| Non-Current Liabilities | |||||
| TOTAL | $1,326 | $1,367 | $748 | $602 | $233 |
| Total Liabilities | $10,995 | $15,749 | $9,897 | $6,383 | $4,572 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,513 | 26,475 | 26,465 | 26,338 | 26,329 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -114,587 | -94,979 | -76,825 | -62,388 | -51,620 |
| Other shareholders' equity | -33 | 853 | 521 | 275 | -719 |
| TOTAL | $161,737 | $180,226 | $196,175 | $208,601 | $216,808 |
| Total Liabilities And Equity | $172,732 | $195,975 | $206,072 | $214,984 | $221,380 |